Pfizer Inc financial data

Symbol
PFE on NYSE
Location
66 Hudson Boulevard East, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 106 % -29.6%
Quick Ratio 27 % -0.15%
Debt-to-equity 139 % +3.76%
Return On Equity 8.77 %
Return On Assets 3.68 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.69B shares +0.33%
Entity Public Float 158B USD -23.7%
Common Stock, Value, Issued 481M USD +0.21%
Weighted Average Number of Shares Outstanding, Basic 5.68B shares +0.32%
Weighted Average Number of Shares Outstanding, Diluted 5.71B shares +0.23%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 62.5B USD +11.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 7.39B USD -18.6%
Income Tax Expense (Benefit) -510M USD +66.8%
Net Income (Loss) Attributable to Parent 7.88B USD -4.75%
Earnings Per Share, Basic 1 USD/shares -5.46%
Earnings Per Share, Diluted 1 USD/shares -5.46%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.43B USD +98.9%
Accounts Receivable, after Allowance for Credit Loss, Current 11.8B USD +7.79%
Inventory, Net 10.9B USD -0.37%
Other Assets, Current 2.95B USD -32.6%
Assets, Current 45.9B USD +8.12%
Other Long-term Investments 1.79B USD -48.7%
Property, Plant and Equipment, Net 18.3B USD -2.43%
Operating Lease, Right-of-Use Asset 2.29B USD -21.7%
Intangible Assets, Net (Excluding Goodwill) 54B USD -14.1%
Goodwill 68.4B USD -1.23%
Other Assets, Noncurrent 9.85B USD -12.1%
Assets 208B USD -5.91%
Accounts Payable, Current 5.24B USD -6.28%
Employee-related Liabilities, Current 2.61B USD +18.9%
Contract with Customer, Liability, Current 1.01B USD -59.6%
Liabilities, Current 36.5B USD -9.99%
Deferred Income Tax Liabilities, Net 2.26B USD +143%
Operating Lease, Liability, Noncurrent 2.29B USD -12.9%
Other Liabilities, Noncurrent 13.3B USD -12.1%
Liabilities 117B USD -8.67%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8.58B USD -10.6%
Retained Earnings (Accumulated Deficit) 120B USD -1.42%
Stockholders' Equity Attributable to Parent 90.3B USD -2.11%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 90.6B USD -2.08%
Liabilities and Equity 208B USD -5.91%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.34B USD +114%
Net Cash Provided by (Used in) Financing Activities -5.23B USD -6%
Net Cash Provided by (Used in) Investing Activities 3.27B USD +89%
Common Stock, Shares Authorized 12B shares 0%
Common Stock, Shares, Issued 9.59B shares +0.32%
Common Stock, Par or Stated Value Per Share 0.05 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 375M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.48B USD +89.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 353M USD -14.9%
Deferred Tax Assets, Valuation Allowance 1.64B USD -5.75%
Deferred Tax Assets, Gross 19.1B USD +0.39%
Operating Lease, Liability 2.64B USD -16.2%
Payments to Acquire Property, Plant, and Equipment 564M USD -19.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 7.06B USD +3065%
Lessee, Operating Lease, Liability, to be Paid 3.2B USD -16.4%
Property, Plant and Equipment, Gross 34.9B USD -0.31%
Operating Lease, Liability, Current 356M USD -32.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -663M USD -50.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 556M USD -17.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 27M shares 0%
Unrecognized Tax Benefits 4.53B USD -5.66%
Additional Paid in Capital 93.9B USD +0.92%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.2B USD -7.69%
Depreciation, Depletion and Amortization 1.62B USD -6.8%
Deferred Tax Assets, Net of Valuation Allowance 17.5B USD +1.01%
Interest Expense 2.96B USD +10.2%